Kevin Bitterman
QuietNamed in filings at Atlas VentureOn the current fund
- Board seats filed
- 13
Named in filings at Atlas VentureOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Renasant Bio | Biotech & pharma | July 2024 | None on file |
| GRO Biosciences | Biotech & pharma | July 2024 | None on file |
| Remix Therapeutics | Biotech & pharma | December 2023 | Seaview Capital Partners |
| Chroma Medicine | Biotech & pharma | February 2023 | None on file |
| Judo Bio | Biotech & pharma | November 2022 | None on file |
| Kinaset Therapeutics | Biotech & pharma | July 2020 | None on file |
| Akero Therapeutics | Biotech & pharma | December 2018 | Venbio Global Strategic |
| Morphic Holding | Biotech & pharma | June 2016 | None on file |
| Editas Medicine | Biotech & pharma | August 2015 | Bain Capital Life Sciences |
| Direct Vet Marketing | Enterprise software | March 2015 | Borealis, HLM Strategic Investment, HLM Venture Partners, Insight |
| Neuronetics | Medical devices | November 2014 | New Leaf |
| Navitor Pharmaceuticals | Biotech & pharma | September 2013 | None on file |
| Kala Pharmaceuticals | Biotech & pharma | February 2012 | Kendall Capital Partners, Lux Capital, TCG Crossover, Tcgx Asia Life Sciences, Third Rock Ventures, Vivo Innovation |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Kevin Bitterman on the board, based on 13 filed seats with a verified or cited source.